Health Trials

Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Efficacy and Safety of HN2301 in Patients With Generalized Myasthenia Gravis (MG)

This is an open label, single arm study, to evaluate safety, tolerability and preliminary efficacy of HN2301 in patients with Generalized Myasthenia Gravis.

Participants needed: 6
Trial details
Phase: Phase 1Age: 18-80Biological sex: AllType: InterventionalSponsor: Shenzhen MagicRNA Biotechnology Co., LtdUpdated: Apr 29, 2026Locations: 1
Eligibility criteria

Age: 18-80 years, no gender restriction; [+6]

Subjects positive for hepatitis B surface antigen (HBsAg) and/or hepatitis B cor... [+11]

Read more
Status: Recruiting

Efficacy and Safety of HN2301 in Autoimmune Diseases（AIDs）

This is an open lable and single arm study, is designed to evaluate the safety and preliminary efficacy of HN2301 in Autoimmune Disease（AID）

Participants needed: 30
Trial details
Phase: Phase 1Age: 18-69Biological sex: AllType: InterventionalSponsor: Shenzhen MagicRNA Biotechnology Co., LtdUpdated: Apr 28, 2026Locations: 1
Eligibility criteria

Patients aged between 18 and 69 (inclusive), of any gender; [+5]

Individuals with positive Hepatitis B surface antigen (HBsAg) and/or Hepatitis B... [+8]

Read more
Status: Not yet recruiting

Safety and Preliminary Efficacy of HN2302 in Patients With Autoimmune Diseases

This is an open-label, single-arm study designed to evaluate the safety and preliminary efficacy of HN2302 in patients with autoimmune diseases, including systemic lupus erythematosus (SLE) and systemic sclerosis (SSc).

Participants needed: 12
Trial details
Phase: Phase 1Age: 18-69Biological sex: AllType: InterventionalSponsor: Shenzhen MagicRNA Biotechnology Co., LtdUpdated: Apr 14, 2026Locations: 1
Eligibility criteria

Adults aged 18 to 69 years, regardless of gender. [+4]

Positive hepatitis B surface antigen (HBsAg), or positive hepatitis B core antib... [+8]

Read more